The effect of interleukin-I f3 (lL-1 (3) on a cerebral artery was investigated in anesthetized dogs, Intracisternal ad ministration of IL-l f3 (0,03 and 0,3 j.Lg) dilated the canine basilar artery in a dose-dependent manner, without affecting systemic blood pressure or heart rate, The increase in diameter induced by 0,3 j.Lg of IL-lf3 was 28.4% ± 13.4% of control at 2 hours and was inhibited by 30 j.Lg of the IL-I f3 receptor antagonist, zinc protoporphyrin (4,5% ± ]3,5%, P < 0,05), Interleukin-l f3 did not affect the concentration of nitric oxide metabolites in CSF. However, there was an increase in the concentration of eicosanoids in CSF, and the elevation of 6-Abbreviations used: COX-2, inducible cyc1ooxygenase; HR, heart rate; IL-II3, interleukin-ll3; iNOS, inducible NOS; 6-keto-PGFla, 6keto-prostaglandin Fla; MABP, mean arterial blood pressure; NOS, nitric oxide synthase; PGEz, prostaglandin E2; PLA2, phospholipase A2; SDS, sodium dodecyl sulfate; TXB2, thromboxane B2; ZnPP, zinc protoporphyrin, 1337 keto-PGF1", paralleled the vasodilation, Pretreatment with 30 j.Lg of the selective inducible cyclooxygenase (COX-2) inhibi
Interleukin-l � (IL-l�) is a proinflammatory cytokine capable of exhibiting a wide spectrum of biologic activi ties, although its constitutive expression in the nervous system is limited, Injection of IL-l � into the cerebral ventricles or specific brain regions has been reported to cause numerous pathologic processes, including fever (Palmi et aI., 1995) , slow-wave sleep (Krueger et aI., 1984) , pituitary adrenal activation (Berkenbosch et aI., 1987; Katsuura et aI., 1988) , hypophagia (Uehara et aI., 1989) , hyperinsulinemia (Cornell and Schwartz, 1989) , behavioral changes (Berkenbosch et aI., 1987) , glial pro liferation (Giuilian et aI., 1988) and neovascularization (Giuilian et aI., 1988) , Recent studies have shown that IL-l � inhibits long-term potentiation (Katsuki et aI., 1990) and 'Y-aminobutyric acid receptors (Miller et aI., 1991) in hippocampal and cortical slices, Interleukin-l � seems to affect many intercellular messages through spe cific IL-l receptors in brain and peripheral tissues, In cerebral diseases, including ischemia, trauma, and hemorrhage, IL-l � mRNA expression has been demon strated to be acutely elevated, probably to mediate acute inflammatory steps (Liu et aI., 1993; McClain et aI., 1987; Minami et aI., 1992) , Expression of IL-l� mRNA has been observed in various cells of the central nervous system, including microglia, astrocytes, and vascular en dothelial cells (Liu et aI., 1993) , Interleukin-l� has been shown to enhance blood flow and exacerbate ischemic brain injury caused by an increase in vascular permeabil ity in a stroke model (Kadoya et aI., 1995; Liu et aI., 1993; Relton and Rothwell, 1992; Yamasaki et aI., 1995) , and IL-l ex dilates pial arterioles through enhanced production of prostanoids in piglets in vivo (Shibata et aI., 1990 (Shibata et aI., , 1996 ,
To evaluate a direct role of IL-l � on the cerebral circulation, we studied the vasoactive effect of IL-l � on the diameter of the basilar artery on angiograms after intracisternal administration of IL-I � in dogs in vivo. The vasodilator mechanism of IL-l � was investigated using pharmacologic and biochemical analysis of cere brospinal t1uid (CSF) and the cerebral arterial wall.
MATERIALS AND METHODS

Animal preparation
Experiments were carried out in accordance with the guide lines for the care and use of animals in the physiologic sciences as approved by the Physiological Society of Japan.
Mature mongrel dogs of either gender, weighing 8 to 14 kg, were anesthetized with ketamine hydrochloride (10 mglkg, in tramuscularly) and pentobarbital sodium (20 mg/kg, intrave nously, followed by 5 mg/kg per hour). Slow intravenous in fusion of saline was maintained during the procedure to prevent dehydration. V e ntilation was controlled through an endotrache al tube, with room air delivered by a respirator (model B2, Igarashi Ika Kogyo Co., Tokyo, Japan). The 'respiratory rate (approximately 12 cycles/min) and tidal volume (20 mLlkg) were adjusted to maintain arterial blood gas levels and pH within physiologic limits. Body temperature was maintained at 37° to 38°C with a heating pad. The systemic mean arterial blood pressure (MABP) and heart rate (HR) were monitored with a catheter placed in the right femoral artery using a pres sure transducer (model AP-601 G, Nihon Kohden Co., Tokyo, Japan) in conjunction with a heart rate coupler (model AT-600G, Nihon Koden Co.).
Angiographic measurement of vascular diameter
The vasodilator effects of IL-l f) on cerebral arteries were determined by means of angiography. A SF catheter was in serted under fluoroscopic control into the vertebral artery via the left femoral artery. Angiography was performed at a fixed magnification with 3 mL of 65% iothalamate meglumine. An giograrns were obtained before, and at 0.5, I, 2, 3, 4.5, and 6 hours after the injection of 1.5 mL of the control or test solu 
Effect of intracisternal IL-ll3 on MABP and HR
The effect of IL-l f) (0.03 or 0.3 fLg doses) on MABP and HR was determined after injection of the test solution into the cis terna magna. In some animals, 1.5 mL of normal saline con taining 75 fLL of phosphate-buffered saline was used as a con trol. All test substances were dissolved in the same amount of normal saline just before use. The pH of all test solutions was close to that of the control solution. 
IL-ll3
To determine whether the effects were mediated by the IL (NS-398), was injected into the cisterna magna IS minutes before the administration of 0.3 J.Lg of IL-l f) to determine whether the effect was mediated by COX-2. The NS-398 was dissolved in ethanol and diluted in 1.5 mL normal saline (final concentration was 0.5%) and injected as described above.
Assay of IL-ll3, nitric oxide metabolites, and eicosanoids in CSF Assays for IL-l f), nitric oxide metabolites, and eicosanoids were performed using 1.5 mL CSF samples obtained before and at 0.5, I, 2, 3, 4.5, and 6 hours after the injection of 1.5 mL of the control or test solution into the cisterna magna. Samples were stored at -80°C until assayed. Interleukin-I f) was mea sured using enzyme-amplified sensitivity immunoassay meth ods (Medgenix, Fleurus, Belgium). The nitric oxide end prod ucts, nitrite and nitrate, were assayed by the Griess reagents method (Cayman Chemical, Ann Arbor, MI, U.S.A.). 6-Keto prostaglandin F la (6-keto-PGF I ,,) ' thromboxane B2 (TXB2), and prostaglandin E2 (PGE2) were measured using commer cially available enzyme immunoassay kits (Amersham, Buck inghamshire, U.K.). In each assay, the sample was assayed in duplicate, and the mean level was used. The limits of detection of these assays were 3.0 pg/mL for 6-keto-PGF la' 3.6 pg/mL for TXB2, 40 pg/mL for PGE2, 2 pg/mL for IL-l f), and 2.5 J.LmollL for nitrite and nitrate.
Canine basilar artery preparations
Mongrel dogs were exsanguinated through the carotid and femoral arteries 6 hours after injection of IL-I f) (0.3 J.Lg) and
were perfused with 500 mL normal saline. The basilar artery was removed carefully with the entire brain. After removal of the arachnoid membrane and connective tissue, the basilar ar tery was quickly frozen in liquid nitrogen and stored at -80°C until further use. Dogs were killed by exsanguination under full anesthesia without injection of IL-l f), and the basilar arteries were used as control samples.
Western blot analysis
The basilar arteries were minced and homogenized in 30 fLL/mg tissue electrophoresis sample buffer (2% sodium do decyl sulfate (SDS), 10% glycerol, 0.1 % bromophenol blue, 2% 2-mercaptoethanol, and 50 mmol/L Tris-HCI, pH 7.2). Af ter sonication, solubilized proteins (10 J.Lg/lane) were subjected to SDS-polyacrylamide gel electrophoresis (7.5% acrylamide, I.O-mm-thick slab gels). Proteins were then transferred to a polyvinylidene difluoride membrane by semidry electroblot ting. The membrane was blocked for I hour at room tempera ture with I % skim milk and incubated with rabbit polyclonal COX-2 antibody (I :500 dilution) for 45 minutes. After wash ing, the membrane was incubated for 30 minutes with donkey anti-rabbit IgG conjugated to horseradish peroxidase (I : 1,000).
Peroxidase activity was visualized with an enhanced chemilu minescence Western blotting detection system (Amersham).
Materials
Interleukin-l f) (recombinant human) was purchased from 
Statistical analysis
Data are expressed as mean ± SD. Changes in vessel diam eter, concentrations of prostanoids, and MABP and HR were evaluated statistically using an analysis of variance for repeated measures. Significant changes were subsequently delineated using the Bonferroni-Dunn method. A probability of less than 0.05 was considered statistically significant. Serial changes in nitric oxide metabolites were assessed by a one-way analysis of variance.
RESULTS
Angiography and concentration of IL-IP
Intracisternal injection of IL-I rp (0.03 f,Lg to 0.3 f,Lg) induced a dose-dependent increase in the internal diam eter of the canine basilar artery, as determined by angi ography (Fig. 1) . The middle portion of the basilar artery was chosen for the quantitative assessment of the change in blood vessel diameter. The maximal dilation induced by 0.3 f,Lg of IL-I rp was 28.4% ± 13.4% of the baseline at 2 hours (Fig. 2) . No significant changes in MABP or HR were detected after administration of IL-I rp, at either dose, during the 6 hours after injection (Table 1) .
The basal concentration of IL-l rp in CSF before injec tion of IL-l rp was 2.8 ± 3.8 pg/mL (n = 10). The con centrations of IL-I rp in CSF after injection revealed a logarithmic disappearance. At 6 hours after injection of 0.3 f,Lg and 0.03 f,Lg of IL-l rp, the concentrations of IL-l rp in CSF were 1.35 ± 0.7 1 ng/mL and 0. 13 ± 0.08 ng/mL, respectively ( Fig. 3 ).
Effect of IL-IP receptor antagonist
Intracisternal injection of the IL-l rp receptor antago nist, ZnPP (30 f,Lg), alone did not significantly affect the diameter of the canine basilar artery. Simultaneous in jection of ZnPP and IL-I rp significantly inhibited the IL-l rp-induced vasodilation (P < 0.05 at 2 and 3 hours; Fig. 4 ).
Concentrations of nitric oxide metabolites and eicosanoids in CSF
The concentration of the nitric oxide metabolites, ni trite and nitrate, in CSF showed no significant increase from control after injection of IL-l rp. The maximum con centration (1.40 ± 0.41 f,LmoIlL) was observed 6 hours after injection of IL-l rp (Fig. 5) .
The basal concentrations of 6-keto-PGF1 a , TXBb and PGE2 in CSF were 0.60 ± 0.20 ng/mL (n = 6), 0.44 ± 0.35 ng/mL (n = 6), and 0.57 ± 0.58 ng/mL (n = 5), respectively. Interleukin-l rp induced a dose-dependent increase in the concentrations of these eicosanoids. The maximum concentrations of 6-keto-PGF1(X, TXB2, and PGE2 induced by IL-lrp (0.3 f,Lg) were 29.6 ± 21.3 ng/mL at 3 hours, 18.2 ± 5.8 ng/mL at 1 hour, and 15.4 ± 4.1 ng/mL at 2 hours, respectively (Fig. 6 ).
Effect of COX-2 inhibitor on basilar artery dilation
Pretreatment with NS-398 (30 f,Lg) for IS minutes be fore IL-l rp injection inhibited the IL-I rp-induced vasodi lation (P < 0.01 at 2 and 3 hours; Fig. 7 ). This pretreat ment alone caused no significant change in the diameter of the basilar artery.
Western blot analysis
Western blot analysis using a specific antibody against the C-terminal fragment of human COX-2 showed that a 68-kD band corresponding to the size of the COX-2 pro tein appeared in basilar artery treated with IL-l rp (0.3 f,Lg); such a distinct band was not detectable m non treated control basilar artery (Fig. 8) .
DISCUSSION
In the present study, intracisternal administration of IL-l rp dilated the canine basilar artery in a dose dependent manner in anesthetized dogs without affecting hemodynamics. Simultaneous injection of the IL-l rp re ceptor antagonist ZnPP significantly inhibited the vaso dilator effect of IL-I rp. The vasodilation was associated with increases in the concentrations of eicosanoids in CSF; in particular, the elevation of 6-keto-PGF1(X was parallel to the vasodilaton induced by IL-l rp. No signifi cant changes in the concentrations of nitric oxide me tabolites in CSF were seen. Pretreatment with the selec- Values are means ± SO; n, number of animals; MABP, mean arterial blood pressure; HR, heart rate; IL, interleukin. tive inducible cyclooxygenase inhibitor NS-398 also sig nificantly inhibited the IL-Ifj-induced vasodilation. A COX-2-like protein was detected in the extract of the basilar artery at 6 hours after injection of IL-Ifj using Western blot analysis. These findings suggest that IL-Ifj acts on specific receptors and the vasodilator effect is mediated through the prostaglandin cascade, especially prostacyclin, stimulated by the induced COX-2. Hemodynamic changes produced by IL-lfj, mediated via prostanoids, especially PGE2, have been well studied. An increase in blood pressure in awake rats after intra peritoneal injection of IL-lfj (Morimoto et aI., 1992) and in awake dogs after intravenous injection of IL-Ifj (Fukushima et aI., 1991) have been documented. In con trast, intravenous injection of IL-lfj decreased systemic arterial blood pressure in anesthetized rabbits (Okusawa et aI., 1988) . After intrathecal administration of IL-lfj, there was no significant change in blood pressure in nor mal anesthetized rats (Plata-Salaman et aI., 1995). Like wise our results showed no change in either mean arterial pressure or heart rate after intracisternal administration of IL-lfj in anesthetized dogs. Doses and injected routes of IL-Ifj, species differences, and animal conditions may partly explain these disparities.
Interleukin-l receptors have been shown to be present throughout the brain, especially where neurons are grouped in tight clusters (Farrar et ai., 1987) . Zinc pro toporphyrin is well known to have anti-inflammatory properties because it inhibits IL-I receptors, and ZnPP has also been shown to reduce brain infarct size and edema formation after ischemia (Kadoya et aI., 1995; Yamasaki et ai., 1995) . In our study, ZnPP alone slightly, but not significantly, decreased the diameter of the bas ilar artery for 3 hours, probably because of impairment of 1[3) . The actual baseline diameter in control, IL-l[3 0.03 lJg, and IL-l[3 0.3 lJg groups are 1.11 ± 0.15 mm, 1.19 ± 0.08 mm, and 1.03 ± 0.06 mm, respectively. Values are mean ± SO; number of animals in parentheses. "Significantly different from before con trol group, P < 0.01. endothelial nitric oxide synthase or guanylate cyclase. Zinc protoporphyrin is known to block heme-dependent enzymes, such as guanylate cyclase, heme oxygenase, and nitric oxide synthase (Luo and Vincent, 1994) . In fact, we demonstrated that ZnPP inhibits the vasodilation induced by L-arginine in this study (data not shown). Simultaneous injection of ZnPP (30 f.1g) with IL-l � (0.3 f.1g) significantly inhibited the vasodilator effect of IL l�. Because the vasodilation of IL-l � is unaffected by nitric oxide formation, we prefer to suggest that the in hibitory effect of ZnPP on IL-l � is mediated through specific receptors. Our results are in agreement with pre vious studies (Plata-Salaman et aI., 1995) that demon strated the requirement for doses of IL-l antagonists 50to 200-fold larger than the administered dose of IL-l to inhibit the IL-l-induced biologic effects.
The concentrations of IL-l � in CSF after injection of IL-l � into the cisterna magna disappeared logarithmi cally. Even 6 hours after injection of 0.3 f.1g of IL-l�, the concentration of IL-l� in CSF was 1.35 ± 0.71 ng/mL, significantly higher than the basal concentration of IL-l � (2.8 ± 3.8 pg/mL). The vasodilator response was maxi mal 2 hours after injection and then gradually declined to 8.6% ± 12.3% of the baseline at 6 hours. This phenom enon seems to be consistent with results obtained by McKean et ai. (1994) showing that only 20% binding of surface receptors with IL-la results in the subsequent desensitization of all cell surface IL-I type I receptors within 4 hours after stimulation of IL-l type I receptor transfected lurkat T cells. These desensitized cells still have unbound IL-l type I receptors on the cell surface, and the affinity of these receptors is normal. This novel pathway for IL-I signaling as a self-regulation system plays an important role in the acute inflammatory re sponse. Cyclooxygenase has a strong resemblance to nitric ox ide synthase (NOS). Both require heme as a cofactor and have constitutive and inducible forms. Interleukin-1 � in duces the inducible form of NOS (iNOS) in rat vascular endothelial cells and cardiocytes (Kanno et aI., 1994; Tsujino et aI., 1994) , and it induces both iNOS and COX-2 in rat islets of Langerhans (Corbett et a!., 1993) . Nitric oxide itself stimulates the activity of cyclooxygen ase (Corbett et aI., 1993; Salvemini et aI., 1993; Tetsuka et aI., 1994) . On the contrary, endogenous PGE2, a COX product, downregu1ates iNOS induction in rat mesangial cells (Tetsuka et aI., 1994) . Nitric oxide synthase and COX pathways interact with each other, and the cross talk between these two pathways may be important in inflammatory responses. In our study, IL-113 stimulated the formation of COX-2 in canine basilar artery, as evi denced by the finding that a selective inhibitor of COX-2 completely inhibited the vasodilation caused by IL-113 (Futaki et aI., 1994; Masferrer et aI., 1994) . Western blot analysis using a specific polyclonal antibody against COX-2 also showed a 68-kD protein in basilar artery extracts 6 hours after IL-113 stimulation. However, IL-l l3 did not stimulate the formation of iNOS. A similar pros taglandin-dependent and nitric oxide-independent re sponse has been demonstrated in human vascular smooth muscle cells (Beasley and McGuiggin, 1995) and in rab bit isolated mesenteric artery (Marceau et aI., 1991) after IL-113 stimulation.
Interleukin-l or endotoxin has been shown to induce prostacyclin predominantly compared with PGE2 in rab bit isolated mesenteric artery (Marceau et aI., 199 1) and in bovine aortic endothelial cells (Akarasereenont et aI., 1995) . Cerebromicrovascular endothelial cell lines pro duce prostacyclin and PGE2 in a ratio of 3:1 (Moore et aI., 1988) . Prostacyclin and TXB2 are thought to be pro- Values are mean ± SD; number of animals in parentheses. Sig nificantly different from before control group, ** P < 0.01, * P < 0.05. duced from cerebral vessels, while PGE2 and PGF2 a are considered products of nervous tissue. Our in vivo results are in agreement with those of Shibata et ai. (1990) . In our experiments, 6-keto-PGF I a was significantly in creased and PGE2 and TXB2 were also increased in the CSF surrounding the canine basilar artery after IL-1 f> administration, and in their experiments, 6-keto-PGF la and a similar concentration of PGE2 were induced in the CSF surrounding the pial arterioles in piglets.
The vasoactivity of PGE2 may be different between the major cerebral arteries and pial arterioles. It has been well known from in vivo studies that PGE2 produces vasoconstriction in the basilar artery in dogs and cats (Handa et aI., 1974; Toda et a!., 1991; White et aI., 1975) , whereas it produces vasodilation in the pial arte rioles in cats and pigs (Armstead, 1995; Ellis et a!., 1979) . It seems that PGE2, in addition to TXB2, a well-known vasoconstrictor (Ellis et aI., 1977) , induced vaso constriction in our study. Significant vasodilation in duced by IL-l f> was observed beginning 2 hours after administration of IL-I f>. This vasodilation probably re flects the increase of the 6-keto-PGF la concentration in CSF, because the increasing pattern of 6-keto-PGF la concentration is parallel to the vasodilation.
The time course of IL-1 -induced cyclooxygenase syn thesis has been shown to be relatively fast (2 to 8 hours) in both in vitro and in vivo systems. The concentration of PGE2 in CSF appeared to be maximal at 100 minutes after intracerebroventricular administration of IL-l f> in rabbits (Palmi et aI., 1995) . Albert et ai. (1994) demon strated an increase in the mRNA for COX-2 within 30 minutes and an increase in the COX-2 protein itself within 2 hours in amnion-derived WISH cells. In human umbilical vein endothelial cells in vitro, the COX-2 pro tein and its enzyme activity appeared at 6 to 8 hours and was correlated with an increase in prostacyclin synthesis (Maier et aI., 1990) . The time course of vasodilation induced by IL-IO' (10.8 /-Lg) or IL-lf> (1.5 /-Lg) was sig nificantly faster than that observed in this study, within 30 minutes in pial arterioles in piglets (Shibata et aI., 1990 (Shibata et aI., , 1996 .
In piglet pial arterioles, the vasodilation induced by IL-1 was accompanied by a significant increase in pros- tanoids (6-keto-PGF1w PGE2, and PGF2o) in CSF (Shi bata et aI., 1990 (Shi bata et aI., , 1996 . These prostanoids caused a va sodilation not only by accumulation of cyclic nucleotide in the smooth muscle cells, but also by stimulation of NOS activity (Armstead, 1995; Shibata et aI., 1990 Shibata et aI., , 1996 . In our study, nitric oxide metabolites in CSF did not increase after IL-113 administration. Based on these findings, we suggest that major arteries and pial arteri oles respond differently to the proinflammatory cytokine IL-l. It appears that prostaglandins in arterioles prefer entially affect endothelial NOS and control the release of nitric oxide, but the prostaglandin cascade' stimulated by IL-II3-induced COX-2 produces a direct vasoactive function without affecting NOS in major arteries.
Another rate-limiting step of prostaglandin formation is the release of arachidonic acid from membrane phos pholipids, which is mediated by phospholipase A2 (PLA2). Two types of PLA2 exist: cytosolic PLA2 and secretory PLA2. Interleukin-113 has been found to induce not only COX-2 but also cytosolic PLA2 in human sy novial cells (Angel et aI., 1994; Hulkower et aI., 1994) and rat mesangial cells (Schalkwijk et aI., 1992) . Pro duction of large amounts of PGE2 is considered to be the cause of rheumatoid arthritis and some renal diseases. Interleukin-l stimulates secretory PLA2 in rat cultured astrocytes (Olea and Arita, 1991) . However, the role of PLA2 in the central nervous system in acute inflamma tion remains unknown.
In conclusion, intracisternal administration of IL-113 dilated the basilar artery in a dose-dependent manner in anesthetized dogs with no systemic hemodynamic ef fects. This vasodilator effect of IL-113 was mediated through specific receptors in the basilar artery. These receptors seem to be linked to the prostaglandin cascade and not to the nitric oxide pathways. The proinflamma tory cytokine IL-113 exerts various effects through these prostanoids, and selective blockage of the induced en zyme may be another potential therapeutic method for patients with acute cerebral disease.
